#pharma packaging companies

[delitealublisterpackingmachine]

blister packing machine -A valuable input on working

Working principle of automatic blister packing machine

Automatic blister packing machines are of 2 types

Cold-forming blister packing machine

Hot-forming blister packing machine

A blister packaging machine creates a cavity known as a blister. The blister resembles the shape of the product to be packed. The blister is produced in plastic or aluminum foil which is in roll form. The operations include ....... Read More

[pharmavisualaid1-blog]

How to Promote Pharma Product with Visual Aids

Discover effective strategies and expert tips for promoting pharmaceutical products using visual aids. Learn how to leverage compelling visuals to enhance your sales pitches and engage healthcare professionals effectively. Dive into our insightful blog to elevate your pharma marketing game today!

[truepharmacia]

Pharmaceutical Packaging Company in India

Top Pharmaceutical Packaging company in India is True Pharmacia. We specialize in offering the pharmaceutical business high-quality packaging solutions. We guarantee that your goods are safe, effective, and compliant with industry standards through our modern facilities and skilled staff. To explore your packaging requirements and advance your pharmaceutical products, get in touch right now.

[mishabiotech]

Allopathic Best Pharma Companies In India

Misha Biotech is a distinguished pharmaceutical company based in India, renowned for its exceptional production of high-quality Allopathic medicines. Our state-of-the-art manufacturing plants are certified by GMP-WHO, ensuring that our products meet the highest quality and safety standards.

Equipped with the latest technology and modern machinery, our infrastructure facilities are second to none. It is no surprise that we are among the top Allopathic best pharma companies in India.

From the very beginning, our unwavering commitment has been to provide our customers with only the best Allopathic medicines. As a result, our products have gained a strong foothold in the market, with high domestic and global demand.

Our consistent performance has placed us at the forefront of the list of Allopathic best Pharma companies in India.

Let’s get in touch!

Call today!

+91 98150 24766 

Visit us to know more!

https://www.mishabiotech.in/allopathic-best-pharma-companies-in-india/

[imprintpackaging]

Printing and Packaging Manufacturer in India - Imprint Packaging

Imprint Packaging is a leading manufacturer of flexible laminated packaging materials in India, including multi-layered pouches, rolls, HDPE/PP fabric laminated sack bags, foil pouches, and water-soluble pouches. We have built a strong name in the flexible packaging industry since our foundation.

We have a state-of-the-art production factory with cutting-edge machinery and equipment that can create 200 metric tonnes of multi-layered pouches and HDPE bags per day. The high-speed automatic eight-color Roto-Gravure ARC printing machines, solventless / solvent-based lamination machines, slitting machines, pouch-making machines, and an extrusion lamination plant are all available at the plant.

Imprint Packaging is a unit of Merino poly pack which was established in 2004. Merino Poly Pack is a manufacturer and wholesaler of Seal Pouch, Stand Up Pouch, and other similar products. Our highly experienced vendors have extensive industry experience in their respective fields of business operations, and their strong support enables us to offer our clients the highest level of satisfaction. Merino Poly Pack understands the modern requirement of on-time delivery of packaging material.

If you are looking for any type of printing & packaging services, please feel free to connect with our team to clarify your doubts!

Link: https://imprintpackaging.in/

[rajatradelink]

Pharmaceutical Packaging Aluminum Foils Manufacturer

Raja Tradelinks Pvt. Ltd. (RTL) is an eminent name in the Packaging Industry. Established in 1963 as Raja Trading Company, a partnership firm, we later transformed into Raja Tradelinks Pvt. Ltd. in the year 2000. Today, after receiving Government of India's recognition, we're an ISO 9001:2015 Certified company, Star Export House.

We as a brand take immense pride in being a one stop solution for all your Pharmaceutical packaging needs. We constantly strive to provide our clients with not only the most premium quality products but also the best in class service. We offer a broad-spectrum of products ranging from Empty Glass Bottles, Aluminum ROPP Caps and Measuring Cups to Dropper Assembly Sets, Empty Printed Cartons, Collapsible Tubes and Aluminum Foils.

RTL have been a prime representative of India's most prominent Glass Bottles manufacturers in the International market. Our wide range of Glass Bottles include Dropper Bottles, Vials, Syrup Bottles, Dry Syrup Bottles, Wide Mouthed Bottles, Flat Bottles and Boston Bottles.

We also offer customized Aluminum ROPP Caps in all standard sizes & a variety of colors that's sure to make our client's design stand out. Our other products include Measuring Cups made of Polypropylene, Dropper Assembly Sets & Printed Cartons in different GSM qualities, medical grade Aluminum Foils and Collapsible Tubes.

[mostlysignssomeportents]

Private equity plunderers want to buy Simon & Schuster

Going to Defcon this weekend? I'm giving a keynote, "An Audacious Plan to Halt the Internet's Enshittification and Throw it Into Reverse," on Saturday at 12:30pm, followed by a book signing at the No Starch Press booth at 2:30pm!

https://info.defcon.org/event/?id=50826

Last November, publishing got some excellent news: the planned merger of Penguin Random House (the largest publisher in the history of human civilization) with its immediate competitor Simon & Schuster would not be permitted, thanks to the DOJ's deftly argued case against the deal:

https://pluralistic.net/2022/11/07/random-penguins/#if-you-wanted-to-get-there-i-wouldnt-start-from-here

When I was a baby writer, there were dozens of large NY publishers. Today, there are five - and it was almost four. A publishing sector with five giant companies is bad news for writers (as Stephen King said at the trial, the idea that PRH and S&S would bid against each other for books was as absurd as the idea that he and his wife would bid against each other for their next family home).

But it's also bad news for publishing workers, a historically exploited and undervalued workforce whose labor conditions have only declined as the number of employers in the sector dwindled, leading to mass resignations:

https://lithub.com/unlivable-and-untenable-molly-mcghee-on-the-punishing-life-of-junior-publishing-employees/

It should go without saying that workers in sectors with few employers get worse deals from their bosses (see, e.g., the writers' strike and actors' strike). And yup, right on time, PRH, a wildly profitable publisher, fired a bunch of its most senior (and therefore hardest to push around) workers:

https://www.nytimes.com/2023/07/18/books/penguin-random-house-layoffs-buyouts.html

But publishing's contraction into a five-company cartel didn't occur in a vacuum. It was a normal response to monopolization elsewhere in its supply chain. First it was bookselling collapsing into two major chains. Then it was distribution going from 300 companies to three. Today, it's Amazon, a monopolist with unlimited access to the capital markets and a track record of treating publishers "the way a cheetah would pursue a sickly gazelle":

https://pluralistic.net/2023/07/31/seize-the-means-of-computation/#the-internet-con

Monopolies are like Pringles (owned by the consumer packaged goods monopolist Procter & Gamble): you can't have just one. As soon as you get a monopoly in one part of the supply chain, every other part of that chain has to monopolize in self-defense.

Think of healthcare. Consolidation in pharma lead to price-gouging, where hospitals were suddenly paying 1,000% more for routine drugs. Hospitals formed regional monopolies and boycotted pharma companies unless they lowered their prices - and then turned around and screwed insurers, jacking up the price of care. Health insurers gobbled each other up in an orgy of mergers and fought the hospitals.

Now the health care system is composed of a series of gigantic, abusive monopolists - pharma, hospitals, medical equipment, pharmacy benefit managers, insurers - and they all conspire to wreck the lives of only two parts of the system who can't fight back: patients and health care workers. Patients pay more for worse care, and medical workers get paid less for worse working conditions.

So while there was no question that a PRH takeover of Simon & Schuster would be bad for writers and readers, it was also clear that S&S - and indeed, all of the Big Five publishers - would be under pressure from the monopolies in their own supply chain. What's more, it was clear that S&S couldn't remain tethered to Paramount, its current owner.

Last week, Paramount announced that it was going to flip S&S to KKR, one of the world's most notorious private equity companies. KKR has a long, long track record of ghastly behavior, and its portfolio currently includes other publishing industry firms, including one rotten monopolist, raising similar concerns to the ones that scuttled the PRH takeover last year:

https://www.nytimes.com/2023/08/07/books/booksupdate/paramount-simon-and-schuster-kkr-sale.html

Let's review a little of KKR's track record, shall we? Most spectacularly, they are known for buying and destroying Toys R Us in a deal that saw them extract $200m from the company, leaving it bankrupt, with lifetime employees getting $0 in severance even as its executives paid themselves tens of millions in "performance bonuses":

https://memex.craphound.com/2018/06/03/private-equity-bosses-took-200m-out-of-toys-r-us-and-crashed-the-company-lifetime-employees-got-0-in-severance/

The pillaging of Toys R Us isn't the worst thing KKR did, but it was the most brazen. KKR lit a beloved national chain on fire and then walked away, hands in pockets, whistling. They didn't even bother to clear their former employees' sensitive personnel records out of the unlocked filing cabinets before they scarpered:

https://memex.craphound.com/2018/09/23/exploring-the-ruins-of-a-toys-r-us-discovering-a-trove-of-sensitive-employee-data/

But as flashy as the Toys R Us caper was, it wasn't the worst. Private equity funds specialize in buying up businesses, loading them with debts, paying themselves, and then leaving them to collapse. They're sometimes called vulture capitalists, but they're really vampire capitalists:

https://www.motherjones.com/politics/2022/05/private-equity-buyout-kkr-houdaille/

Given a choice, PE companies don't want to prey on sick businesses - they preferentially drain off value from thriving ones, preferably ones that we must use, which is why PE - and KKR in particular - loves to buy health care companies.

Heard of the "surprise billing epidemic"? That's where you go to a hospital that's covered by your insurer, only to discover - after the fact - that the emergency room is operated by a separate, PE-backed company that charges you thousands for junk fees. KKR and Blackstone invented this scam, then funneled millions into fighting the No Surprises Act, which more-or-less killed it:

https://pluralistic.net/2020/04/21/all-in-it-together/#doctor-patient-unity

KKR took one of the nation's largest healthcare providers, Envision, hostage to surprise billing, making it dependent on these fraudulent payments. When Congress finally acted to end this scam, KKR was able to take to the nation's editorial pages and damn Congress for recklessly endangering all the patients who relied on it:

https://pluralistic.net/2022/03/14/unhealthy-finances/#steins-law

Like any smart vampire, KKR doesn't drain its victim in one go. They find all kinds of ways to stretch out the blood supply. During the pandemic, KKR was front of the line to get massive bailouts for its health-care holdings, even as it fired health-care workers, increasing the workload and decreasing the pay of the survivors of its indiscriminate cuts:

https://pluralistic.net/2020/04/11/socialized-losses/#socialized-losses

It's not just emergency rooms. KKR bought and looted homes for people with disabilities, slashed wages, cut staff, and then feigned surprise at the deaths, abuse and misery that followed:

https://www.buzzfeednews.com/article/kendalltaggart/kkr-brightspring-disability-private-equity-abuse

Workers' wages went down to $8/hour, and they were given 36 hour shifts, and then KKR threatened to have any worker who walked off the job criminally charged with patient abandonment:

https://pluralistic.net/2023/06/02/plunderers/#farben

For KKR, people with disabilities and patients make great victims - disempowered and atomized, unable to fight back. No surprise, then, that so many of KKR's scams target poor people - another group that struggles to get justice when wronged. KKR took over Dollar General in 2007 and embarked on a nationwide expansion campaign, using abusive preferential distributor contracts and targeting community-owned grocers to trap poor people into buying the most heavily processed, least nutritious, most profitable food available:

https://pluralistic.net/2023/03/27/walmarts-jackals/#cheater-sizes

94.5% of the Paycheck Protection Program - designed to help small businesses keep their workers payrolled during lockdown - went to giant businesses, fraudulently siphoned off by companies like Longview Power, 40% owned by KKR:

https://pluralistic.net/2020/04/20/great-danes/#ppp

KKR also helped engineer a loophole in the Trump tax cuts, convincing Justin Muzinich to carve out taxes for C-Corporations, which let KKR save billions in taxes:

https://pluralistic.net/2020/06/02/broken-windows/#Justin-Muzinich

KKR sinks its fangs in every part of the economy, thanks to the vast fortunes it amassed from its investors, ripped off from its customers, and fraudulently obtained from the public purse. After the pandemic, KKR scooped up hundreds of companies at firesale prices:

https://pluralistic.net/2020/03/30/medtronic-stole-your-ventilator/#blackstone-kkr

Ironically, the investors in KKR funds are also its victims - especially giant public pension funds, whom KKR has systematically defrauded for years:

https://pluralistic.net/2020/07/22/stimpank/#kentucky

And now KKR has come for Simon & Schuster. The buyout was trumpeted to the press as a done deal, but it's far from a fait accompli. Before the deal can close, the FTC will have to bless it. That blessing is far from a foregone conclusion. KKR also owns Overdrive, the monopoly supplier of e-lending software to libraries.

Overdrive has a host of predatory practices, loathed by both libraries and publishers (indeed, much of the publishing sector's outrage at library e-lending is really displaced anger at Overdrive). There's a plausible case that the merger of one of the Big Five publishers with the e-lending monopoly will present competition issues every bit as deal-breaking as the PRH/S&S merger posed.

(Image: Sefa Tekin/Pexels, modified)

I’m kickstarting the audiobook for “The Internet Con: How To Seize the Means of Computation,” a Big Tech disassembly manual to disenshittify the web and bring back the old, good internet. It’s a DRM-free book, which means Audible won’t carry it, so this crowdfunder is essential. Back now to get the audio, Verso hardcover and ebook:

http://seizethemeansofcomputation.org

If you’d like an essay-formatted version of this post to read or share, here’s a link to it on pluralistic.net, my surveillance-free, ad-free, tracker-free blog:

https://pluralistic.net/2023/08/08/vampire-capitalism/#kkr

[charlie-rulerofhell]

Two days back, Chris did a twitch stream in which he answered fans' questions both in English and in German. So this is yet another translation / summary of all the nice things Chris has to say. It's gonna be way shorter than the Saltatio Mortis podcast, both because I took the notes simultaneously to doing uni work, so I probably didn't catch everything that might be interesting, and because for some answers I couldn't remember in retrospective if he gave them in German or in English, and I didn't want to spam you with info that you might have already heard yourself :D

So, here we go:

when comparing their own smaller concerts with big Iron Maiden performances: "To play in a small club in England in front of 500 people that all know you, that's like going to a small family gathering with family members that you see every day anyway. To play with Iron Maiden in front of 20,000 people is like visiting a huge wedding celebration, where you might know 20 people but the other 200 you have never seen before even though you're related to them, so you first gotta introduce yourself." (just loved the analogy here :D)

about the next record: At the end of the year, a full cover album is gonna be released that will style-wise stay similar to the B&G era, and apparently the 15 years anniversary tour next year will also keep that style. After that, however, Chris said that the only logical consequence for them, after all this brightness and colour, was to go into the complete opposite direction. So the next (proper) record will be the darkest album that they have done so far (with 'dark' not necessarily meaning 'hard', so it's not gonna be Death Metal, but it will in fact keep parts of the current 80s vibe). There is some concept that is already planned out, but it's not a religious one, nor a mythological one. The theme will be rather dark-romantic, dealing with our human emotional abysses.

Someone commented: "On pictures you seem quite photogenic", to which Chris jokingly replied that this were his big secret: He's not really photogenic, but he's good at seeming that way. The question continued with asking if he had ever modelled or been asked to model, and he gave some interesting reply. In fact, Chris has been asked for various model jobs in the past, but he always refused. He said that he would generally be up for the idea, but if he does promote a product / a company with his face, he has to be able to fully stand behind it. Sometimes it might not have been the choice of clothing etc. that he would personally like, but in most cases the decision was due to the company that he could not support, for example if the clothes were produced under unethical conditions. He also mentions that he had had a request for some allergy meds recently, that he actually would have liked to do (as someone who struggles with allergies himself), but the pharma trust responsible for that product worked with animal testing, so again, he refused.

he made a joke about Klaas being so small that he would actually be standing below the camera in that moment, holding up signs with jokes for Chris to read :D

about the decision for B&G for the ESC instead of One Last Song and The Curtain Falls that were also on the shortlist: With both songs the main problem was that they wouldn't have managed to produce a qualitative music video in time. OLS was also too long, and Chris didn't feel good with any parts being cut, while TCF was still kind of in the production phase. B&G had the full package: it is catchy and recognisable, has a good message, a provocative song title that also reflects the bands different sides, there was a music video and even a whole album of the same name.

someone prompts the idea of a calendar with all of the beautiful pics that Lennard is taking, and Chris likes the idea and actually writes it down! (thinking about 2 group pictures + 1 for the cover and 2 x 5 portrait shots)

he likes the pink hair colour atm (even if it was actually supposed to be red), and thinks about bleeching it platinum again later this month, while still keeping half the hair pink (I think we would all love to see that ;D)

about never playing Not My Enemy: Chris says he is kinda scared to play it live. He wrote the song shortly after the start of the war against the Ukraine, so the meaning is very important to it. He would not want to play it at a festival or at any other place where most people don't know the song and the lyrics, and might even start moshing to it. If it were at a full LOTL show where most people know the song and can feel the meaning, then maybe, but generally it gives him physical pain to even think about performing it live.

and finally about collaborations with other ESC artists: What Chris can confirm is that there will be songs written together with La Zarra (as soon as they find the time). Besides that, there is also another collab that is already underway, but Chris does not yet want to give away with whom

Alright, that's all of my notes. If I missed anything that you are interested in, or you want a full translation of any part, as always, feel free to hit me up :)

[casca-remedies]

Increasing Demand for Ayurvedic Pain Relief Oil

Indians have been using Ayurvedic pain relief oil since ancient times. Ayurveda is rooted deeply in Indian culture and history. In those ancient times, Indians were aware of the medicinal properties of herbs and plants. Therefore, they were using a blend of those herbs and plant extracts to relieve pain in joints and muscles. In modern times, we precure our knowledge and heritage of Ayurveda to produce and manufacture the same Ayurvedic pain-relieving oil. The only difference is that we manufacture and pack them in modern packaging for public use. But it is the same old essence of ancient Ayurveda and herbal medicine. 

There are many recognized Ayurvedic Medicine Manufacturers in India that are making very effective and mint quality Ayurvedic herbal pain oils. These herbal oils are effective in relieving muscle and joint pain. Most of the time, they are very effective in treating common body pain. Pain around the knees, wrists, and musculoskeletal joints can be relieved by using an effective Ayurvedic painkiller oil. 

These oils are blends of selective and effective plant and herb extracts. This oil penetrates the skin and provides relief from pain and swelling. Rubbing affected areas also improves blood circulation, which eventually relaxes the muscles and provides relief from strain and stiffness. In total, these Ayurvedic painkiller oils are very effective and safe to use. 

Uses and Benefits of Ayurvedic Pain Relief Oil

Herbal and Ayurvedic painkiller oils are safe to use. Anyone suffering from joint and muscle pain can use these oils for a longer period of time. Being herbal in nature, they do not produce any side effects. Herbally blended oils are extremely effective in treating chronic muscle and joint pains. These oils have inflammatory properties that reduce swelling and provide relaxation to muscles from stiffness and strains. They are able to cure mostly all types of muscles and pain associated with bones. 

These Ayurvedic Pain Relief Oil are best for both osteoarthritis and arthritis. They can provide relief for a long time. 

Best Ayurvedic Medicine Manufacturers in India

As we know, India is a land of Ayurveda. This is why Indians have faith and trust in Ayurvedic medicinal treatment methods. India is the biggest market for Ayurvedic and herbal products.

To meet this huge market demand for herbal medicines, manufacturing companies in India are producing very large quantities of herbal products. These big manufacturers also provide lucrative Ayurvedic PCD franchises for herbal medicines and products.

Ayurvedic PCD franchises products are one of the most profitable business ventures in recent times. Since the Indian consumer market for herbal and Ayurvedic products is huge, these PCD franchise programs are creating tons of opportunities to grow in the pharma market. And Casca Remedies is one of those PCD pharma franchises that enables its partner to expand and grow in the pharma market as an individual entrepreneur.

Their inhouse Ayurvedic painkiller oil, EVOJOINT, is best selling product on the market. That is why Casca Remedies is best for owning an Ayurvedic pharma franchise. 

[makpharmausa]

As we step into 2023, it is essential to stay updated on the latest trends and innovations in pharma packaging. In this article, we will explore the key trends that are shaping the industry and the innovative solutions being adopted by a pharma packaging company.

[pharmavisualaid1-blog]

Creative Designers for Pharma Leave Behind Literature

Discover innovative leave behind literature designed by creative professionals tailored specifically for the pharmaceutical industry. Elevate your brand's presence and engage healthcare professionals effectively with compelling designs that leave a lasting impression.

[reddancer1]

Big Pharma will have to answer to the American people

Big Pharma will have to answer to the American people

One of my top priorities is to substantially reduce the price of prescription drugs in America

By Sen. Bernie Sanders

It is no great secret that millions of Americans feel that Congress is more interested in protecting large corporations than looking out for ordinary people.

That is never clearer than when we talk about our broken health care system, and the outrageous price of prescription drugs in this country.

The truth is, if you ask most Americans – Democrats, Republicans, independents, progressives, conservatives – they will agree: we are getting ripped off, big time, by the pharmaceutical industry.

As a nation, we spend almost twice as much per capita as any other country on health care – over $13,000 for every man, woman and child. Even for those with insurance, costs are so high that medical bills are often the number one cause of bankruptcy in the United States.

And one of the major reasons for the high cost of health care in America is that we pay, by far, the highest prices in the world for prescription drugs.

You tell me: why does Merck charge diabetes patients in the United States $6,900 for Januvia when the exact same product can be purchased in Canada for $900 and just $200 in France?

Why does Johnson & Johnson charge Americans with arthritis $79,000 for Stelara when it can be purchased for just $16,000 in the United Kingdom? And why does Bristol Myers Squibb charge patients in our country $7,100 for Eliquis when the same product can be purchased for just $900 in Canada and just $650 in France?

On and on it goes. Almost every prescription drug costs far more in the United States than it does in other countries.

The good news is that we are beginning to take on the greed of the pharmaceutical industry. Medicare, for the first time ever, is negotiating the price of some drugs, including Januvia, Stelara and Eliquis.

The bad news is that the pharmaceutical industry is doing everything it can to stop these negotiations, and prevent Congress from making prescription drugs affordable for all Americans – not just those on Medicare.

The giant pharmaceutical and health insurance lobbies have spent huge amounts of money over the past decades to ensure that their profits come before the health of the American people.

Over the past 25 years, the drug companies have spent $8.5 billion on lobbying. Today, they have some 1,800 well-paid lobbyists in Washington, D.C. – including former leaders of the Republican and Democratic parties. Unbelievably, that is more than three lobbyists for every member of Congress.

During that same period, they have provided over $700 million in campaign contributions. And they are equal opportunity contributors. They contribute heavily to both Republican and Democratic candidates.

The result of congressional inaction is that these large corporations have driven up the prices of prescription drugs to the point that one out of four Americans cannot afford the medicine their doctors prescribe.

Meanwhile, while millions of Americans suffer – and some die – because they can’t afford the prescription drugs they need, 10 of the top pharmaceutical companies in the country made over $110 billion in profits in 2022 and paid their CEOs outrageously high compensation packages.

As the chairman of the Senate Committee on Health, Education, Labor and Pensions (HELP), one of my top priorities is to substantially reduce the price of prescription drugs in America. One of the ways to do that is to hold the chief executives of some of the largest pharmaceutical companies in our country accountable for their actions.

That is why I have invited Robert Davis, the CEO of Merck; Joaquin Duato, the CEO of Johnson & Johnson; and Chris Boerner, the CEO of Bristol Myers Squibb, to a hearing to discuss what they are doing to lower drug prices in America.

Why did we ask these CEOs to come before us? Because the American people deserve answers to some pretty simple questions.

For example: Why is it that the median price of new prescription drugs in America is now over $220,000 – including many new cancer drugs? How does it happen that while millions of Americans cannot afford the prescription drugs they need, when major drug companies in America spend more on stock buybacks and dividends than they do on research and development?

Why is there an enormous lack of transparency in how your companies set drug prices?

These very straightforward questions are on the minds of millions of Americans. These are questions that the CEOs of major pharmaceutical companies have a responsibility to answer.

And let’s be clear: these are not struggling companies forced to charge high prices to survive. Believe me, they are not going broke. In 2022, Johnson & Johnson made nearly $18 billion in profits, paid its CEO over $27 million in compensation and spent over $17 billion on stock buybacks and dividends.

That same year, Merck made $14.5 billion in profit, handed out over $7 billion in dividends to their wealthy stockholders and paid its CEO over $52 million in compensation.

And Bristol Myers Squibb made $6.3 billion in profits last year, while recently spending over $12 billion on stock buybacks and dividends and giving its CEO over $41 million in compensation.

I am proud of what the committee has already accomplished.

Last year, the CEO of Moderna committed during a HELP Committee hearing that his company would set up a patient assistance program so that no one in America would have to pay for their vaccine out of pocket. In a separate HELP Committee hearing last May, the CEO of Eli Lilly committed that his company would not raise prices on existing insulin products.

The committee’s efforts are paying off, but much more needs to be done.

I look forward to the hearing on Feb. 8, with the CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb, to discuss how they will substantially lower the price of prescription drugs in America.

[truepharmacia]

Pharmaceutical Blister Packaging in India

The pharmaceutical business continually uses pharmaceutical blister packing to store and safeguard specific dosages of pharmaceuticals, vitamins, and other healthcare supplies. Discover top-quality pharmaceutical blister packaging in India with True Pharmacia. Our innovative and reliable packaging solutions ensure the safety and integrity of your medications.

[numaxstudies]

August 24, 2022

I got a good two hours of studying at work yesterday. Workload is bad today but I’ll try to get an hour in.

I’m a full-time on-site Quality Specialist at a Pharma Packaging company. I handle all aspects of QMS and I’m the only one in my role. With chronic health issues this makes it harder to have the energy to study full-time.

However I am done delaying my dreams to become an attorney. I’m 74 days away from my LSAT and 15 points short of my goal. I refuse to give up.

[imprintpackaging]

Laminated Roll Manufacturer in India | Imprint Packaging

Imprint Packaging is a leading manufacturer of flexible laminated packaging materials in India, We’ve always believed in providing consumers with a One-Stop Solution using cutting-edge technology. Reaching nationwide in India we provide Laminated Pouches, Laminated Roll, Tri Laminated Pouches, Bi Laminated Pouches, Standy Pouch, Zipper Pouch, BOPP Woven Sack Bag that are the best in print and packaging industry We are experts in using the most innovative techniques to provide you with the best printing solutions. Our proactive approach, attention to detail, superior digital print quality, competitive pricing, and flexible service guarantee customer satisfaction whether its in Gujarat, Maharashtra, Madhya Pradesh, Haryana and Delhi.

The choice of Packaging Format say either ‘rolls’ or ‘pouches’ depends upon the machine; especially for the Form Fill Seal Machine that brings printed laminated rolls into pouch form whereas filling & sealing operations are done simultaneously with faster speed. It should not delaminate while pouching and should possess effective bond strength and sealable characteristics.

https://imprintpackaging.in/laminated-roll/